Nokchipja Labcell ranked among the top searched stocks for 3 days within the past month.


As of 9:30 AM on the 5th, Nokchipja Labcell is trading at 116,800 KRW, down 2.42% from the previous day. This represents a 67.34% increase compared to December 3rd. Nokchipja Labcell is known as a cell therapy research and development company.

Over the past 5 days, individual investors have net sold 434,308 shares, while foreigners and institutions have net bought 254,468 shares and 169,278 shares, respectively.


On January 4th, Nokchipja Labcell became a market issue with the headline 'Moderna vaccine contract manufacturing rumor leads to limit-up.'



※Source: AI Investment Assistant AI Lassi


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing